Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First‐in‐Man Study

Chronic lung transplant rejection (termed chronic lung allograft dysfunction [CLAD]) is the main impediment to long‐term survival after lung transplantation. Bone marrow‐derived mesenchymal stromal cells (MSCs) represent an attractive cell therapy in inflammatory diseases, including organ rejection,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chambers, Daniel C., Enever, Debra, Lawrence, Sharon, Sturm, Marian J., Herrmann, Richard, Yerkovich, Stephanie, Musk, Michael, Hopkins, Peter M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442848/
https://www.ncbi.nlm.nih.gov/pubmed/28186707
http://dx.doi.org/10.1002/sctm.16-0372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442848/
https://www.ncbi.nlm.nih.gov/pubmed/28186707
http://dx.doi.org/10.1002/sctm.16-0372

Ejemplares similares